The functional enrichment analysis on the 635 resistant genes associated with cancer drugs indicate that these genes are enriched in the above mentioned resistant pathways and those related to drug therapies, e.g. ABC transporter, apoptosis, cell proliferation and P53 pathways. The gene discussed is ABCG2; the disease is cancer.